AEGIS MEDIC AEGIS MEDIC INC on LinkedIn

AI-Enhanced Guardian Imaging System for Medics

AEGIS MEDIC turns any handheld ultrasound probe into an expert-guided diagnostic tool.

Hardware-agnostic AI middleware, purpose-built for the prolonged-field-care environment. Runs entirely offline on ruggedized mobile hardware and gives real-time, turn-by-turn guidance to 68W Combat Medics, Pararescue, and civilian EMTs.

  • Offline-first
  • Confidence-gated
  • Workflow-integrated

Patent Pending — U.S. Non-Provisional Patent Application No. 19/688,914, filed May 27, 2026, claiming priority to U.S. Provisional Application No. 63/981,331 (filed February 2026). Atty. Docket No. AEGIS-001-NP.

The Problem

Hemorrhage is the leading cause of preventable death on the battlefield.

Portable ultrasound hardware already exists. The expertise to interpret its images in a Care Under Fire scenario is a rare and perishable skill.

The Solution

Expert interpretation, on any probe, with no cloud.

AEGIS MEDIC sits between the probe and the medic. It runs on the edge in austere or connectivity-degraded environments and tells the operator what it sees — and when it isn't sure.

Capabilities

Built for the point of injury.

01

Hardware agnostic

Integrates with existing COTS probes (Butterfly, GE Vscan, Philips Lumify) via standard SDKs. No new proprietary hardware.

02

Autonomous triage

Automated detection of critical trauma indicators, including pneumothorax and intraperitoneal hemorrhage, using the eFAST protocol.

03

Edge-native

All inference runs locally on ruggedized mobile hardware. Confidence-gated output flags indeterminate results instead of guessing.

Architecture
Edge-native AI — runs offline, on device
Target users
Army Medics (68W), Pararescue (PJ), civilian paramedics
Regulatory pathway
FDA 510(k), Class II SaMD
Current status
Non-provisional patent application filed (USPTO No. 19/688,914, May 27, 2026). AEGIS MEDIC INC was incorporated in Delaware in October 2026 as the independent company behind AEGIS MEDIC; the patent application has been assigned to it from Wilson Intelligence Services LLC. The founding team holds MTEC membership (via Wilson Intelligence Services LLC; AEGIS MEDIC INC enrollment in process) and tracks DIU solicitations in AI-enabled medical systems. Working demonstration available under NDA.

Intellectual Property

20 claims across system, method, and machine-readable medium.

AEGIS MEDIC is the subject of U.S. Non-Provisional Patent Application No. 19/688,914, filed May 27, 2026. The application is owned by AEGIS MEDIC INC, a Delaware corporation, by assignment from Wilson Intelligence Services LLC. Its technical scope covers:

  • Offline AI inference on ruggedized portable computing platforms
  • Confidence-gated triage output with explicit indeterminate-result handling
  • Probe-vendor-agnostic image normalization
  • Multi-pathway data synchronization, including removable-media (sneakernet) pathways
  • Cryptographically signed post-market model updates with rollback retention
  • Operator-feedback-driven retraining loop compatible with FDA PCCP frameworks
  • Handheld, head-mounted, wrist-mounted, vehicle-mounted, aid-station, and unmanned-vehicle form factors

The application claims priority to U.S. Provisional Application No. 63/981,331 (filed February 2026). Continuation applications may follow.

AEGIS MEDIC™ is a trademark of AEGIS MEDIC INC.

Interested in partnership or R&D?

We're working with DoD partners and medical device manufacturers.

For investment inquiries, contact us at contact@wilsonintel.com or follow AEGIS MEDIC INC on LinkedIn.

Partnership & R&D Investor inquiries Follow on LinkedIn

Founded by Benjamin Ian Wilson, Wilson Intelligence Services LLC. Investor and partnership inquiries: contact@wilsonintel.com

AEGIS MEDIC

© 2026 AEGIS MEDIC INC. All Rights Reserved.

Intellectual Property Notice: AEGIS MEDIC™ is a trademark of AEGIS MEDIC INC. The technology described on this site is subject to pending patent applications, including U.S. Non-Provisional Application No. 19/688,914 and U.S. Provisional Application No. 63/981,331.

0